company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,116000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,116000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,116000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,323000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,744000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1067000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-951000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-652000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-671000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1622000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1622000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1622000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1622000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-14.88
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-14.88
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q3,2013-01-01,2013-03-31,2014-05-14 16:33:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-14.88
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,258000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,258000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,258000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,781000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1443000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2224000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1966000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5105000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5098000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7064000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7064000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7064000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7064000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-64.81
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-64.81
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-64.81
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,515000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,515000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,515000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1190000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2230000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3420000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2905000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2162000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2170000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-735000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-735000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-735000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-735000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.74
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.74
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,2015-02-11 08:21:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.74
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,232000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,232000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,232000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1364000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2128000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3492000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3260000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-336000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-328000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3588000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3588000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3588000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3588000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-25.45
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-25.45
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,141000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q3,2014-01-01,2014-03-31,2015-05-11 16:26:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-25.45
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,124000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,124000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,124000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1847000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2702000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4549000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4425000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-115000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-96000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4521000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4521000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4521000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4521000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,92.54
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,92.54
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3568000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q4,2014-04-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,92.54
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,705000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,705000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,705000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1681000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4433000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6114000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5409000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5381000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5381000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5381000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5381000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15800000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15800000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15646000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,652000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,652000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,652000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1916000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3438000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5354000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4702000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,52000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4650000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4650000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4650000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4650000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16422000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16422000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,2016-02-08 16:06:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,284000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,284000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,284000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2571000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4104000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6675000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6391000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,67000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,65000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6326000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6326000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6326000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6326000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16463000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16463000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,2016-05-09 16:49:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,713000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,713000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,713000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6143000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8743000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8030000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,69000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7961000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7961000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7961000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7961000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16253000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16253000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11062000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11062000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11062000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2787000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17488000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20275000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9213000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,90000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,90000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9123000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9123000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9123000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9123000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17164000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17164000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12189000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12189000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12189000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2116000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7203000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9319000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2870000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,175000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,175000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3045000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3045000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3045000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3045000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17998000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18262000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17900000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,2017-02-08 16:31:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11997000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11997000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11997000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2362000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7868000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10230000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1767000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,202000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,202000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1969000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1969000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1969000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1969000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18033000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18472000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17900000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:05:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12113000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12113000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12113000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2809000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6817000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9626000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2487000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,244000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,241000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2728000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2728000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2728000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2728000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17810000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17810000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17300000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11806000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11806000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11806000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2846000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5571000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8417000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3389000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,236000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,236000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3625000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3025000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3025000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3025000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18050000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18445000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10933000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10933000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10933000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2740000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6041000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8781000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2152000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,227000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,227000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2379000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1779000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1779000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1779000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18067000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18393000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17800000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,2018-02-09 16:12:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8388000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8388000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8388000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2921000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6303000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9224000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-836000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,236000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,236000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18081000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18081000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24000000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,2018-05-08 16:50:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8346000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8346000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8346000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2847000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8302000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11149000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2803000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,253000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-47000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,206000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2597000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,600000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3197000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3197000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3197000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18072000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18385000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20400000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10315000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10315000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10315000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3706000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8276000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11982000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1667000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,270000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,270000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1397000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1397000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1397000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1397000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18088000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18088000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17500000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4852000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4852000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4852000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3368000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7726000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11094000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6242000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,271000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,261000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5981000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-791000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5190000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5190000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5190000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18094000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18094000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17900000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,2019-02-07 16:06:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3603000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3603000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3603000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3946000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7353000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11299000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7696000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,325000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,325000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7371000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,725000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-5000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8101000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8101000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8101000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18112000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18112000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18000000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 16:33:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5416000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5416000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5416000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3369000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8826000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12195000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6779000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,435000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-115000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,320000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6459000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,138000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-15000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6612000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6612000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6612000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18105000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18105000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14034000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14034000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14034000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3213000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10065000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13278000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,756000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,471000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,471000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1227000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-8000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18128000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18158000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17100000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5934000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5934000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5934000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3022000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7583000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10605000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4671000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,520000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,520000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4151000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-11000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4181000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4181000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4181000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18094000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18094000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,2020-02-05 16:15:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21318000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21318000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21318000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3110000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7203000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10313000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11005000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,512000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,512000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11517000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-9000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11489000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11489000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11489000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18166000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18324000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,2020-05-13 16:17:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,406000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,406000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,406000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3514000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8332000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11846000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11440000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,506000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,446000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,952000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10488000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-7000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10514000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10514000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10514000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18157000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18157000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
